Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Oxalobacter formigenes strain HC-1

EU orphan designation number: EU/3/14/1346   
Active ingredient: Oxalobacter formigenes strain HC-1
Indication: Treatment of short bowel syndrome
Sponsor: OxThera AB
c/o Ekonomi Klara Papper, P.O. Box 1062, 101 39 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/080/14 (2014)7645 of 15/10/2014
18/06/2018 Change of name and/or address of sponsor